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Abstract
Background: The issue remains unresolved as to whether low frequency magnetic fields can affect
cell behaviour, with the possibility that they may be in part responsible for the increased incidence
of leukaemia in parts of the population exposed to them.
Methods: Combined treatment of HeLa cells with gamma-irradiation (1, 3 and 5 Grays) and extra
low frequency magnetic fields of ~50 Hz was carried out under rigorously controlled conditions.
Results: Synchronised cells progressing from S-phase arrived at mitosis on average marginally
ahead of irradiation controls not exposed to ELF. In no instance out of a total of twenty separate
experiments did this "double-insult" further delay entry of cells into mitosis, as had been
anticipated.
Conclusion: This apparently "non-genotoxic" agent (ELF) appears to be capable of affecting cells
that would normally arrest for longer in G2, suggesting a weakening of the stringency of the late
cycle (G2) checkpoint.
Introduction
Some epidemiological studies purport to show a relation-
ship between cancer incidence and environmental expo-
sure to extremely low frequency (ELF) electromagnetic
fields (EMFs) [1,2]. Others have failed to find a correla-
tion [3,4], and Campion [5] and more recently Park [6]
have concluded that any association is probably far too
tenuous and insignificant to warrant further investigation.
The inability of laboratory studies to provide convincing
evidence that ELF fields can alter cells seems to support
such a view. Negative evidence proves little, and despite
such statements, a nagging concern that some as yet unex-
plained ability of ELF-EMFs to modify cellular processes,
such as implied by the enhancement ("promotion"?) of
leukemogenesis in man. Without some clear endpoint to
measure, few have known where to begin in a systematic
laboratory approach, which is made worse by the lack of
a tangible hypothesis.
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Ionising radiation is undoubtedly associated with car-
cinogenesis, since it is known to increase the rate of genet-
ic mutation and thus the incidence of cellular defects
leading to the emergence of malignant phenotypes. Envi-
ronmental exposure to ELF-EMFs is reputedly far too weak
to cause genetic damage [7] and in vitro assays of muta-
genicity have been negative [8]. However, since not all car-
cinogens have to be genotoxic, it is possible that some
agents participate indirectly in the induction of genetic
changes required to bring about carcinogenesis. The spon-
taneous gene mutation rate in human cells is high and
mechanisms operate which repair these errors, thereby re-
ducing genomic instability, with the incidence of cancer
being orders of magnitude higher in their absence [9].
Damaged cells can either engage a programmed cell death
pathway, effectively committing suicide [10,11], or arrest
in cycle until the damage is repaired during the "time-out"
response to the so-called DNA damage cell cycle check-
points [12,13]. While both mechanisms help maintain ge-
nomic stability, they themselves are targets for non-
genotoxic carcinogens.
Of the two main checkpoints, the one in G1 largely pre-
vents duplication of genetic errors, whilst the one in G2
stops cells entering mitosis with damaged chromosomes.
Loss of checkpoint stringency is a feature of oncogenic
transformation [14,15]; the gene encoding the p53 tu-
mour suppressor that plays such a pivotal role in the G1
DNA damage checkpoint is mutated in >50% of human
cancers [16], with inactivation of the protein itself by as-
sociation with viral oncoproteins accounting for many
others. Indeed, p53 knock-out mice spontaneously devel-
op a high frequency of tumours [17,18] due to failure in
G1 arrest following DNA damage [19,20], with a resultant
predisposition to gene amplification and genetic instabil-
ity [21,22]. Conversely, if "proliferative impetus" is main-
tained when cells should have arrested in their cycle
because of reduced checkpoint stringency, this may lead
to the propagation of either somatic or induced muta-
tions, which is a hypothetical mechanism for non-genoto-
xic carcinogenicity.
Table 1: Statistics applied to flow cytometry data
Exposure Category Dose (Gy) Statistical test Sample Size (n) Significance (p)
1 & 2 0 Wilcoxon matched pairs 22 ns
3 & 4 1 " 13 0.05
3 & 4 3 " 25 0.01
3 & 4 5 " 8 0.05
3 & 4 5 Student's t-test 4 0.05
3 & 4 1, 3 & 5 Wilcoxon matched pairs 20 0.01
Table 2: Perpendicular components of background time-varying and static magnetic fields measured at location of sample holders
Component of System Active (Yes/No) Time-Varying Field Static Field
coils A,B no 3nT 50.3 µT
coils C,D no 3nT 45.6 µT
Amplifier and Signal Generator no
coils A,B no 3nT
coils C,D no 3nT
Amplifier and Signal Generator yes
coils A,B yes 2mT*
coils C,D no 0.38 µT*
Amplifier and Signal Generator yes
* With alternate Helmholtz pairs active the background time-varying field in the non-active coils was found to be 0.38 µT.Cancer Cell International 2002, 2 http://www.cancerci.com/content/2/1/3
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Figure 1
A : Magnetic field distribution in the vertical plane; (- - - - -) represents the boundary of the ± 2.5% cylindrical uniform magnetic
field; (- - -) represents the boundary of the sample holder. B: Magnetic field distribution in the horizontal plane demonstrating
cylindrical symmetry; (- - - -) represents the boundary of the ± 2.5% cylindrical uniform magnetic field; (- - -) represents the
boundary of the sample holder.
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Extensive cell proliferation studies that we have carried
out over nearly 5 years have yielded only negative results
when cells have been exposed to 50 Hz, 2mT magnetic
fields for up to 72 h, i.e. no discernible effect of the fields.
In agreement with the majority of published results, stud-
ies on the growth-related enzyme, ornithine decarboxyla-
se, in murine L929 fibroblasts show it was unaffected
[[23], and unpublished data], contrary to the findings of
Litowitz et al. [24]. However, when cells were subjected to
a mild thermal stress (39°C) at the same time as being ex-
posed to 50 Hz magnetic fields for up to 72 h, a small in-
crease in the rate of proliferation was noted compared to
cultures subjected to only the small rise in temperature
[23]. This effect was seen for magnetic field intensities
ranging from 100 µT to 2mT and suggests that cell prolif-
eration/behaviour could be modified by ELFs in cells al-
ready responding to another environmental stress. Two
previous reports have explored a similar approach.
Hintenlang [25] found an increase in near tetraploid chro-
mosome complements in human lymphocytes irradiated
with doses of up to 4Gy from a 137Cs source which were
subsequently cultured in 60 Hz magnetic fields of up to
1.4mT, providing evidence that cellular mechanisms of ra-
diation damaged cells could be modulated. And
Rosenthal and Obe [26] found a significant increase in the
frequency of sister chromatid exchanges in human lym-
phocytes pre-treated with antineoplastic drugs and subse-
quently cultured in a 5mT 50 Hz field, which is highly
relevant to our finding (see Discussion). We surmised that
a double insult would further delay the entry of irradiated
cells into division in synchronized HeLa cultures when an
ELF magnetic field was also applied.
Results and discussion
ELF EMFs and premitotic delay following genotoxic stress
HeLa cells are demonstrably deficient in the G1 DNA
damage cell cycle checkpoint [27] due to PHV E6 inactiva-
tion of p53 [29,30], allowing the effect of magnetic field
exposure on the stringency of the G2 DNA damage check-
point to be analysed in isolation. The G2 block is a univer-
sal cell response to DNA damaging agents [31–34],
showing that this checkpoint is susceptible to partial loss
of stringency rather than complete inactivation. Cells re-
leased from double thymidine block were irradiated 4 h
later in mid-S phase with 1, 3 or 5 Grays of gamma radia-
tion. These levels might be considered high in these stud-
ies, but were chosen after preliminary experiments were
done because they produced the most consistent delays in
the entry of cells into mitosis. Once irradiated, the incuba-
tion was continued with or without continuous incident
magnetic fields, and the appearance of post-mitotic G1
cells was monitored by flow cytometry at various times up
to a maximum of 24 h (field characteristics shown in Fig
1; see Material and Methods section).
Figures 2 to 8 show the results as determined by flow cy-
tometry. Cells released from the double thymidine block
at time-zero that had not been exposed to gamma-radia-
tion (Group1) completed mitosis on schedule within 12
h [27]. The magnetic fields of 2mT (Group 2) had no ef-
fect on their progression into division. Gamma-irradiated
cells slowly regained their ability to enter and complete
M-phase, but were considerably delayed compared to
Groups 1 and 2, as seen in the subsequent 24 h follow-up
period (Group 3).
Irradiated cells that were also incubated in the presence of
a 2mT magnetic field (Group 4) similarly showed a con-
siderable delay in progressing through mitosis. However,
decomposition of the flow-cytometry histograms suggests
that the cells were entering G1 earlier that their matched
controls (Group 3), which would only be consistent with
a reduced G2 checkpoint stringency. Further, this effect was
more prominent with increasing doses of gamma radia-
tion. Out of a total of over 20 experiments, 80% showed
this effect; equally noteworthy is that in no experiment
was the reverse seen. Table 1 gives the statistical analysis
showing the significant difference between Groups 3 and
4.
Further comments
ELF-EMFs of environmentally significant field strengths
(~2mT) shortens the pre-mitotic delay following DNA
damage in HeLa cell cultures prevented from reaching mi-
Figure 2
Flow cytometry histograms of synchronised HeLa S3 cells.
From left to right the histograms correspond to 7.5, 9, 10.5,
11.5 and 13 h after release of the second thymidine block.
Categories 3 and 4 have been irradiated with a dose of 1 Gy
in early S-phase.
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tosis on schedule by gamma-irradiation. Since EMF treat-
ment alone lacked any discernible effect, it is clear from
this work, as in our previous studies, that biological sys-
tems like this have to be rendered exquisitively sensitive to
environmental agents before any discernible effect of an
agency such as ELF-EMFs might be detected. In human
populations at risk to leukemia, irrespective of the causa-
tive agent or the genetic disposition of the individuals to
this disorder, a low but consistent frequency of cancer it-
self indicates that the system is delicately poised, and
hence the influences of a non-genotoxic agent, such as
ELF-EMFs, could operate by compromising the late cycle
checkpoint under these circumstances. Such an effect
might well be "felt" in a population in which the back-
ground incidence of cancer in the most susceptible early
age-groups was low, even with an apparent doubling in
the incidence of the disease. Furthermore, if attenuation
of the G2 checkpoint can be implicated as one possibility,
by inference it follows that the same is probably true of at-
tenuation of the other major cell cycle checkpoint in G1
Figure 3
Bar charts illustrating the proportion of cells at different stages in the cell cycle derived from the decomposition of flow cytom-
etry histograms. Irradiated cells have been given 1 Gy in early S-phase.
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(the R or Restriction Point), shown to be exacerbated by
the action of non-genotoxic agents such as phenobarbital
by Gonzales et al. [35]. This has in fact been proposed as
the primary mechanism of this drug's well-recognised ef-
fect on carcinogenesis. Thus deficiencies in crucial cell cy-
cle control mechanisms allow the propagation of genetic
defects and contribute to the increased genetic instability
leading to cancer. These observations therefore define a
novel and plausible mechanism by which ELF-EMFs might
also be included as a non-genotoxic carcinogen. Despite
the "artificiality" of our test system and the levels of these
agencies being considerably above those that might be en-
countered in nature, the very fact that delay in mitosis is
not exacerbated by a double insult, but in general is re-
duced, has obvious implications which cannot be ignored,
even if these findings are in no way directly translatable
into possible environmental reasons for increased "geno-
toxic"/carcinogenic sequelae.
To date we have no explanation as to how these EMFs
might alter pre-mitotic activity at the molecular level. Pre-
vious data on the effects of ELF in synchronised Tetrahyme-
na cell cultures seemed to indicate the initially expected
extra delay caused by a second insult. However, these or-
ganisms are exceedingly sensitive to heat and a 1.6°C rise
in temperature in the active coil delivering ELFs was found
to be responsible [36]. We have circumvented this prob-
lem here by introducing fans that stabilise the tempera-
tures within the active and inactive coils at exactly the
same level within the hot room, and allow us to adjust
down the room temperature should it rise to an unaccept-
able level. But the involvement of a very small heat-shock
is much less likely to affect mammalian cells, many of
which have a growth optimum of ~38.5°C. Since the usual
outcome of raised temperatures is an exacerbation of any
additional physical or chemical insult on the cells, ELF
once again seems to be doing the very opposite in our ex-
periments by reducing rather than further protracting the
inevitable delay due to irradiation. In brief, the differences
between Groups 3 and 4 cannot be attributed to tempera-
ture asymmetry.
We surmised that cyclin B/p34cdc2 kinase activity would
show no difference between Groups 1 and 2, indicating
that ELFs alone do not increase kinase activity. The G2/M
transition is catalysed by cyclin-dependent kinase (cdk)
(p34cdc2) [37], activity of which is principally regulated by
association with cyclin B [38] and a series of phosphoryla-
tion/ dephosphorylation reactions [39,40]. In Groups 3
and 4 we had initially expected a drop in kinase activity
following irradiation followed by a steady rise with time
as the delay elapsed and cells prepared for division. But in
three all experiments performed, we found that Group 4
kinase activity, assayed by a modification of the method
of Matsushime et al. [41], rose above that in Group 3 at an
earlier time (6 h), commensurate with a faster transit into
division. However, these experiments did not show statis-
tically significant elevations in each case, hence more con-
clusive results cannot be reached until further work is
done. However, it can be reported that in no instance has
the cyclin kinase activity of ELF-exposed cells lagged be-
hind the sham-exposed controls in either the X-irradiated
or non-X-irradiated groups. An increase in cyclin B phos-
phorylation would be commensurate with a shortening in
ELF-EMF treated cells of the G2 delay, and would confirm
the otherwise seemingly counterintuitive finding to the
expected further protraction of this period, and implicat-
ing magnetic field in reducing the stringency of the G2
checkpoint.
Increase in cyclin B and/or cdk1 expression demonstrably
accelerates G2 progression, and clearly more exacting
work now needs to be done on gene expression under
these conditions, with emphasis on expression of the
mRNA of these proteins. The absence of an observable ef-
fect upon unirradiated cultures implicates the arrest-re-
sponse mechanism itself (i.e. the damage sensor, the
signal transduction pathway, cak inhibition, or whatever)
as the primary site of action. While these processes remain
relatively obscure, others have reported that magnetic
fields can have profound effects upon a diverse group of
cellular processes. Therefore interrogation of this control
Figure 4
Flow cytometry histograms of synchronised HeLa S3 cells.
From left to right the histograms correspond to 7.5, 9, 10.5,
11.5 and 13 h after release of the second thymidine block.
Categories 3 and 4 have been irradiated with a dose of 3 Gy
in late S/early G2 phase.
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complex and its suspected modulation by ELF is an im-
portant focus for future work. At present it is unlikely that
these studies can be repeated and extended to test our hy-
pothesis, unless more serious attention is paid to its impli-
cation.
We also concede that at present these time-consuming ex-
periments have allowed us little opportunity to explore
more comprehensively doses levels and different treat-
ment schedules using the two agencies. Also agencies oth-
er than gamma-irradiation need to be carefully
considered. Nevertheless, we believe that our data demon-
strates for the first time an unanticipated effect of ELF on a
cellular response to incipient injury. The hypothesis that
ELF might be capable of exacerbating an inherent or in-
duced genetic instability by reducing or attenuating the
stringency of the late-cycle (G2) checkpoint, allowing cells
to progress into and sometimes through mitosis before
pre-mitotic inflicted damage has been adequately re-
paired, may well be testable in other more sensitive ways
and within other systems.
We concede, however, that we have not demonstrated that
ELF increases the incidence of cellular transformation. In-
deed, our cell system – which already exhibits a highly de-
ranged malignant phenotype – might be considered a far
less acceptable cell type than normal phenotypes which
have been chosen for such demonstrations in other cell
systems [24,36]. Equally, the absence of a functional G1
DNA damage control and the lowered stringency of the
G2 checkpoint in HeLa cells (although the relative "intact-
ness" of the G2 checkpoint cannot be disputed since these
Figure 5
Bar charts illustrating the proportion of cells at different stages in the cell cycle derived from the decomposition of flow cytom-
etry histograms. Irradiated cells have been given 3 Gy in late S/early G2 phase.
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cells nevertheless arrest pre-mitotically following any dis-
turbance in their preparation for division) may also have
influenced the responses observed. While we feel that cells
of normal phenotype may prove superior "models" in fu-
ture work, it can be argued that work on transformed cells
is still relevant because ELF might require some predispo-
sition of cells (or some point of inherent/ induced genetic
instability) which becomes further unbalanced and gives
an abnormal response sooner than otherwise expected,
and from which aberrant subclones of a more anaplastic
nature arise. Thus the recent work of Still et al. [42] on Ju-
rkat cells, which are highly sensitive to their environmen-
tal conditions, may itself be a valid approach, although in
this latest study these authors saw no clear difference be-
tween Ca2+-dependent gene expression in exposed cells
which might have arisen from previously reported chang-
es in intracellular free Ca2+ levels [43].
Materials and Methods
Cell culture and synchronisation
Mycoplasm-negative human cervical epithelial carcinoma
(HeLa) cells, certified as this cell type, as required by the
UKCCCR guidelines, were cultured in DMEM (4.5 g l-1
modification) supplemented with 10% calf serum, 80 µg
ml-1 streptomycin and 100 units ml-1 penicillin at 37°C in
a humidified 5% CO2 atmosphere. Cells were synchro-
nised at the G1/S boundary by double thymidine block, as
in our previous studies [27].
Magnetic fields
Cells were cultured in a 50 Hz, 2mT root mean squared
electromagnetic field applied perpendicular to the cell
monolayers and generated with a Helmholtz configura-
tion of coils. Two Helmholtz pairs were used so that sam-
ples could be either exposed to an applied magnetic field
or sham exposed, i.e. identical environmental conditions
but without magnetic field exposure. The homogeneity of
the field in the coils is shown in Fig. 1A and 1B. Measure-
ment of the magnetic field conditions, including both
time-varying and static fields, was made using a search
coil type sensor and a Bartington's MAG-03MC Fluxgate
Magnetic Field Sensor. Both had calibrations traceable to
national standards. Measurements of the perpendicular
components of the background time-varying fields and
the static fields are shown in Table 2.
Cell cultures were housed in two hermetically sealed, cy-
lindrical perspex flasks commensurate with the ± 2.5%
uniform volume exhibited by the Helmholtz pairs (see
legend to Figure 1A and 1B). Sealable openings were used
to provide a 5% CO2 in air atmosphere and allow inser-
tion of a temperature probe. Temperature control was
achieved by housing the exposure systems in a 37°C hot-
room and using an in-line duct fan to provide a fast air
flow (maximum 460 m3 h-1) directly on to the flasks by
use of ventilation ducting and a suitable Y-tube connector.
Temperature differences between the two flasks were kept
to within ± 0.1°C.
Exposure conditions of cell cultures
For the purpose of investigating whether ELF magnetic
fields can modulate post-irradiation G2 checkpoint func-
tion cell cultures were subjected to one of four environ-
mental conditions hereafter referred to as categories 1 to
4. For the flow cytometry experiments cultures were
grown in 30 mm diameter dishes and were subjected to
the exposure in the Groups shown below immediately fol-
lowing release of a double thymidine block:
Group 1 Cultures grown under normal conditions, i.e.
37°C in a 5% CO2/air atmosphere.
Group 2 As for Group 1 but continuously exposed to a
2mT, 50 Hz magnetic field with a perpendicular orienta-
tion relative to the cell monolayer.
Group 3 Irradiated using a 137Cs source in the range 1–5
Gy. Subsequently cultured as Group 1.
Group 4 Irradiated with 137Cs and then immediately and
continuously exposed to a 2mT, 50 Hz magnetic field with
a perpendicular orientation relative to the cell monolayer.
Figure 6
Flow cytometry histograms of synchronised HeLa S3 cells.
From left to right the histograms correspond to 9.5, 11, 12.5,
13.5 and 15 h after release of the second thymidine block.
Categories 3 and 4 have been irradiated with a dose of 5 Gy
in early S-phase.
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The 137Cs irradiator was housed in a separate building re-
sulting in a transit time of approximately 20 min before
cultures were back in the hot room. Except for the time in
the gamma-irradiation source, the cultures were kept in a
polystyrene box with 37°C water bottles to maintain their
temperature.
Flow cytometry
Nuclei were isolated and stained with propidium iodide
[28]. Nuclear fluorescence (DNA content) was recorded
for each cell of doublet discriminated populations with a
Coulter EPICS Profile II machine. Not less than 10,000
nuclei were processed per sample. Cell cycle phases were
obtained by decomposition of the frequency histograms
by the half-peak reflection method, using an algorithm in
"Cytologic" software (Coulter Electronics).
Abbreviations
ODC, ornithine decarboxylase; HPV, human papilloma-
virus; HEPES, N-2-hydroxyethypiperazine-N'-2-
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Figure 7
Bar charts illustrating the proportion of cells at different stages in the cell cycle derived from the decomposition of flow cytom-
etry histograms. Irradiated cells have been given 5 Gy in early S-phase
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